-transparent.png){kind=logo}
Five patients with resistant non-Hodgkin lymphoma (NHL) were given granulocyte-macrophage colony-stimulating factor (GM-CSF, 250 micrograms/m2 daily) after the BEAM pretransplant chemotherapy regimen (carmustine 300 mg/m2, etoposide 1.2 g/m2, cytarabine 800 mg/m2, melphalan 140 mg/m2) because persistent lymphoma cell infiltration of the bone marrow precluded autologous bone-marrow transplantation (BMT). In three patients full haemopoietic reconstitution occurred, with similar kinetics to that seen after autologous BMT. The other two patients died without sustained haemopoietic recovery. GM-CSF may replace autologous BMT in highly selected cases of NHL with progressive disease and bone-marrow involvement.
J P Laporte, and
L Fouillard, and
L Douay, and
I Eugene-Jolchine, and
F Isnard, and
J Stachowiak, and
A Najman, and
N C Gorin
March 1991,
Experimental hematology,
J P Laporte, and
L Fouillard, and
L Douay, and
I Eugene-Jolchine, and
F Isnard, and
J Stachowiak, and
A Najman, and
N C Gorin
January 1993,
European journal of cancer (Oxford, England : 1990),
J P Laporte, and
L Fouillard, and
L Douay, and
I Eugene-Jolchine, and
F Isnard, and
J Stachowiak, and
A Najman, and
N C Gorin
January 1990,
Blood,
J P Laporte, and
L Fouillard, and
L Douay, and
I Eugene-Jolchine, and
F Isnard, and
J Stachowiak, and
A Najman, and
N C Gorin
January 1990,
International journal of cell cloning,
J P Laporte, and
L Fouillard, and
L Douay, and
I Eugene-Jolchine, and
F Isnard, and
J Stachowiak, and
A Najman, and
N C Gorin
January 1993,
Stem cells (Dayton, Ohio),
J P Laporte, and
L Fouillard, and
L Douay, and
I Eugene-Jolchine, and
F Isnard, and
J Stachowiak, and
A Najman, and
N C Gorin
January 1989,
Bone marrow transplantation,
J P Laporte, and
L Fouillard, and
L Douay, and
I Eugene-Jolchine, and
F Isnard, and
J Stachowiak, and
A Najman, and
N C Gorin
March 1993,
Experimental hematology,
J P Laporte, and
L Fouillard, and
L Douay, and
I Eugene-Jolchine, and
F Isnard, and
J Stachowiak, and
A Najman, and
N C Gorin
October 1998,
Bone marrow transplantation,
J P Laporte, and
L Fouillard, and
L Douay, and
I Eugene-Jolchine, and
F Isnard, and
J Stachowiak, and
A Najman, and
N C Gorin
July 1996,
British journal of haematology,
J P Laporte, and
L Fouillard, and
L Douay, and
I Eugene-Jolchine, and
F Isnard, and
J Stachowiak, and
A Najman, and
N C Gorin
December 1991,
Behring Institute Mitteilungen,
